Quick Answer
GUIDED THERAPEUTICS INC reported Research And Development Expense of $469.0 thousand for the year ending 2025.
- GUIDED THERAPEUTICS INC showed a decrease of -10.8% in Research And Development Expense from 2024 to 2025.
- This data is from GUIDED THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), GUIDED THERAPEUTICS INC's Research And Development Expense has declined by 74.0%.
- Historical annual values: Fiscal year 2025: $469.0 thousand | Fiscal year 2024: $526.0 thousand | Fiscal year 2023: $228.0 thousand | Fiscal year 2022: $77.0 thousand | Fiscal year 2021: $69.0 thousand | Fiscal year 2020: $143.0 thousand | Fiscal year 2019: $122.0 thousand | Fiscal year 2018: $244.0 thousand | Fiscal year 2017: $334.0 thousand | Fiscal year 2016: $733.0 thousand | Fiscal year 2015: $1.48 million | Fiscal year 2014: $2.79 million | Fiscal year 2013: $2.74 million | Fiscal year 2012: $3.23 million | Fiscal year 2011: $2.78 million | Fiscal year 2010: $1.81 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: